| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41296-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74513 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64761-100ug | |||
| BSA Free | NB100-64761-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61681-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61727-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61855-0.025ml | |||
![Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/BATF3-Antibody-Western-Blot-NBP2-41296-img0002.jpg "Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.")
![Immunohistochemistry: BATF3 Antibody [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunohistochemistry-NBP2-41296-img0003.jpg)
![Immunofluorescence: BATF3 Antibody [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunofluorescence-NBP2-41296-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419313277.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202420285889.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419201566.gif)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419172279.gif)
![Western Blot: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TIA1.](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Western-Blot-NBP2-46132-img0008.jpg "Western Blot: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TIA1.")
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0007.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0001.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0002.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0003.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0004.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0005.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0006.jpg)
![TIA1 Antibody (OTI1D7)[NBP2-46132]Simple Western� analysis of endogenous protein TLE1 from A549 lysates (0.2 mg/mL) using TLE1 Mouse Monoclonal Antibody . The virtual lane view (left) shows the target (as indicated) at 1:50 dilution of primary antibody. The corresponding electropherogram view (right) plots chemiluminescence by molecular weight along the capillary at a 1:50 dilution of primary antibody. This experiment was performed under reducing conditions on the Jess� Simple Western instrument from ProteinSimple, a Bio-Techne brand, using the 12�230 kDa Separation Module.](http://images.novusbio.com/fullsize/nbp2-46132_mouse-tia1-mab-oti1d7-simple-western-1311202512362223.jpg%253fstore=america&image-type=image)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power")
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 followed by horseradish peroxidase conjugated Goat anti Mouse IgG1 as a detection reagent. Medium power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunohistochemistry-Paraffin-NB100-64761-img0002.jpg)
![Flow Cytometry: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Staining of Con A activated rat spleen cells with Mouse anti Rat CD25: Biotin](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Flow-Cytometry-NB100-64761-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody, red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. High power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0001.jpg)
![Western Blot: PD-L1 Antibody [NB300-903] - Staining of U2OS cell lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/PD-L1-Antibody-Western-Blot-NB300-903-img0002.jpg "Western Blot: PD-L1 Antibody [NB300-903] - Staining of U2OS cell lysate (35 ug protein in RIPA buffer). Antibody at 0.1 ug/mL. Detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: PD-L1 Antibody [NB300-903] - Immunofluorescence analysis of paraformaldehyde fixed U2OS cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing membrane and cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/PD-L1-Antibody-Immunocytochemistry-Immunofluorescence-NB300-903-img0004.jpg)
![Flow Cytometry: PD-L1 Antibody [NB300-903] - Flow cytometric analysis of paraformaldehyde fixed Jurkat cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/PD-L1-Antibody-Flow-Cytometry-NB300-903-img0005.jpg)
![Western Blot: PD-L1 Antibody [NB300-903] - Staining of Human Heart lysate (35 ug protein in RIPA buffer). Antibody at 0.01 ug/mL. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/PD-L1-Antibody-Western-Blot-NB300-903-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: PD-L1 Antibody [NB300-903] - Immunofluorescence analysis of paraformaldehyde fixed AA431 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).](http://images.novusbio.com/fullsize/PD-L1-Antibody-Immunocytochemistry-Immunofluorescence-NB300-903-img0003.jpg)
![Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. IHC for IL-17A on mouse skin. Scale bar is 100 um. The number of IL-17A-expressing cells was counted in five high-power fields (HPF) chosen at random in each slide by three different pathologists. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0109297) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-TC11-18H10-Immunohistochemistry-Paraffin-NBP1-72027-img0003.jpg "Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Treatment with HBOT or PFD decreased IL-17A expression in the AD lesions. IHC for IL-17A on mouse skin. Scale bar is 100 um. The number of IL-17A-expressing cells was counted in five high-power fields (HPF) chosen at random in each slide by three different pathologists. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0109297) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: IL-17/IL-17A Antibody (TC11-18H10) [NBP1-72027] - Analysis of anti-IL-17 antibody of mouse spleen at concentration 10 ug/ml.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-TC11-18H10-Immunohistochemistry-Paraffin-NBP1-72027-img0002.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-17/IL-17A Antibody (TC11-18H10) - Azide and BSA Free [NBP1-72027] - TG2-dependent chemokine production in keratinocytes is critical for IL-17-producing CCR6+ gamma δT-cell & neutrophil dermal infiltration.a, b Effect of DMSO- or IMQ-treated WT- or TG2−/−-CM on CCR6+ gamma δT-cell (a) & CD11b+ Ly-6G+ cell (b) migration according to Transwell migration assays. Flow cytometric analysis of the percentage of cells migrating toward the CM in the presence or absence of anti-CXCL1 (a) & anti-CCL20 (b) antibodies (n = 3/group). c, d WT & TG2−/− mouse-derived CCR6+ gamma δT-cell (c) & CD11b+ Ly-6G+ cell (d) migration in response to recombinant mouse CCL20 & CXCL1, respectively. Data represent the mean ± SEM (n = 3/group). *p < 0.05; **p < 0.01. e, f Cells were isolated from the back skin of WT & TG2−/− mice treated with IMQ for four consecutive days & analyzed by flow cytometry. Representative flow cytometric profiles of CCR6+ gamma δTCRlow cells (e) & CD11bhigh Ly-6G+ cells (f). The percentage of cells is shown. Data represent the mean ± SEM (n = 9/group). g Skin sections were immunostained with CCR6 (green)- & IL-17 (red)-specific antibodies. Nuclei were stained with DAPI (blue). Scale bar, 100 μm. h–j Back skin was separated into epidermis & dermis & analyzed by RT-PCR for IL-17-producing gamma δT-cell markers (h) (Ccr6 & Il23r), IL17 & related cytokines (i) (Il17a, Il17f, & Il22), & myeloid cell-derived cytokines (j) (Il12a & Il23a). Data represent the mean ± SEM (n = 11/group). *p < 0.05; **p < 0.01 vs. WT mice. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/32355189), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-72027_rat-il-17-il-17a-mab-tc11-18h10-azide-and-bsa-free-310202416171471.jpg)
![Immunocytochemistry/Immunofluorescence: CD2 Antibody (OX-34) [NB100-65228] - (A, B, C) Egg chambers at S6 stained with antibodies against SMRTER and Hindsight (Hnt) (A), CD2 (B), or Cut (C). (D) An egg chamber at S4 stained with antibodies against SMRTER and Cut. (E, F) Egg chambers at S8/S9 stained with antibodies against SMRTER and CD2 (E) or Hnt (F). (G) An egg chamber at S10A stained with antibodies against SMRTER and Hnt.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Immunofluorescence-NB100-65228-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD2 Antibody (OX-34) [NB100-65228] - (A, B, C) Egg chambers at S6 stained with antibodies against SMRTER and Hindsight (Hnt) (A), CD2 (B), or Cut (C). (D) An egg chamber at S4 stained with antibodies against SMRTER and Cut. (E, F) Egg chambers at S8/S9 stained with antibodies against SMRTER and CD2 (E) or Hnt (F). (G) An egg chamber at S10A stained with antibodies against SMRTER and Hnt.")
![Flow Cytometry: CD2 Antibody (OX-34) [NB100-65228] - Figure A. RPE conjugated Mouse anti Rat CD2 and FITC conjugated Mouse IgM isotype control. Figure B. RPE conjugated Mouse anti Rat CD2 and FITC conjugated Mouse anti Rat CD3.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Flow-Cytometry-NB100-65228-img0003.jpg)
![Flow Cytometry: CD2 Antibody (OX-34) [NB100-65228] - Figure A. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse IgG2a isotype control. Figure B. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse anti Rat CD2.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Flow-Cytometry-NB100-65228-img0001.jpg)
![Flow Cytometry: CD2 Antibody (OX-34) [NB100-65228] - Figure A. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse IgG2a isotype control. Figure B. FITC conjugated Mouse anti Rat CD3 and RPE conjugated Mouse anti Rat CD2.](http://images.novusbio.com/fullsize/CD2-Antibody-OX-34-Flow-Cytometry-NB100-65228-img0002.jpg)
![Western Blot: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Western blot analysis of extracts of various cell lines, using HLA DQA1 Rabbit mAb (NBP3-15364) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Western-Blot-NBP3-15364-img0004.jpg "Western Blot: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Western blot analysis of extracts of various cell lines, using HLA DQA1 Rabbit mAb (NBP3-15364) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.")
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Immunohistochemistry of paraffin-embedded mouse spleen using HLA DQA1 Rabbit mAb (NBP3-15364) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Immunohistochemistry-Paraffin-NBP3-15364-img0003.jpg)
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Immunohistochemistry of paraffin-embedded rat spleen using HLA DQA1 Rabbit mAb (NBP3-15364) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Immunohistochemistry-Paraffin-NBP3-15364-img0001.jpg)
![Immunohistochemistry-Paraffin: HLA DQA1 Antibody (7W0M7) [NBP3-15364] - Immunohistochemistry of paraffin-embedded human spleen using HLA DQA1 Rabbit mAb (NBP3-15364) at dilution of 1:100 (40x lens).Perform microwave antigen retrieval with 10 mM PBS buffer pH 7.2 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/HLA-DQA1-Antibody-7W0M7-Immunohistochemistry-Paraffin-NBP3-15364-img0002.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Mouse liver tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-52202517172868.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Mouse spleen tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-52202517172834.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Rat spleen tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-5220251725197.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Human liver tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-5220251726030.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Human colon tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-52202517202942.jpg)
![Immunohistochemistry: HLA DQA1 Antibody (7W0M7) [HLA DQA1] - Immunohistochemistry analysis of paraffin-embedded Human tonsil tissue using HLA DQA1 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval performed with 0.01M Citrate Bufferr (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15364_rabbit-hla-dqa1-mab-7w0m7-5220251718958.jpg)
![Western Blot: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis using CD183 mAb against HEK293 (1) and CD183 (AA: extra mix)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-Western-Blot-NBP2-61681-img0006.jpg "Western Blot: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis using CD183 mAb against HEK293 (1) and CD183 (AA: extra mix)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis of paraffin-embedded esophageal cancer tissues using CD183 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-Immunohistochemistry-NBP2-61681-img0004.jpg)
![Flow Cytometry: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis of Ramos cells using CD183 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-Flow-Cytometry-NBP2-61681-img0008.jpg)
![Western Blot: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis using CD183 mAb against human CD183 (AA: extra mix) recombinant protein. (Expected MW is 38.3 kDa)](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-Western-Blot-NBP2-61681-img0005.jpg)
![Western Blot: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis using CD183 mouse mAb against Hela (1) and L-02 (2) cell lysate.](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-Western-Blot-NBP2-61681-img0007.jpg)
![Immunohistochemistry: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis of paraffin-embedded cervical cancer tissues using CD183 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-Immunohistochemistry-NBP2-61681-img0003.jpg)
![Flow Cytometry: CXCR3 Antibody (5C10E6) [NBP2-61681] - Analysis of Jurkat cells using CD183 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-Flow-Cytometry-NBP2-61681-img0002.jpg)
![ELISA: CXCR3 Antibody (5C10E6) [NBP2-61681] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CXCR3-Antibody-5C10E6-ELISA-NBP2-61681-img0001.jpg)
![Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mAb against HEK293 (1) and CD2 (AA: 25-140)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Western-Blot-NBP2-61727-img0006.jpg "Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mAb against HEK293 (1) and CD2 (AA: 25-140)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry-Paraffin: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of endometrial cancer tissues using CD2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Immunohistochemistry-NBP2-61727-img0004.jpg)
![Flow Cytometry: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of HepG2 cells using CD2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Flow-Cytometry-NBP2-61727-img0008.jpg)
![Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mAb against human CD2 (AA: 25-140) recombinant protein. Expected MW is 39.2 kDa.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Western-Blot-NBP2-61727-img0005.jpg)
![Western Blot: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis using CD2 mouse mAb against MOLT4 (1), MCF-7 (2), L1210 (3), U937 (4), and NIH3T3 (5) cell lysate.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Western-Blot-NBP2-61727-img0007.jpg)
![Immunohistochemistry-Paraffin: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of rectum cancer tissues using CD2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Immunohistochemistry-NBP2-61727-img0003.jpg)
![Flow Cytometry: CD2 Antibody (3D1E3) [NBP2-61727] - Analysis of HeLa cells using CD2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-Flow-Cytometry-NBP2-61727-img0002.jpg)
![ELISA: CD2 Antibody (3D1E3) [NBP2-61727] - Black line: Control Antigen (100 ng); Purple line: Antigen (10 ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/CD2-Antibody-3D1E3-ELISA-NBP2-61727-img0001.jpg)
![Western Blot: Complement C3 Antibody (4C6A8) [NBP2-61855] - Analysis using C3C mAb against human C3C (AA: 1521-1649) recombinant protein. (Expected MW is 40.7 kDa)](http://images.novusbio.com/fullsize/Complement-C3-Antibody-4C6A8-Western-Blot-NBP2-61855-img0006.jpg "Western Blot: Complement C3 Antibody (4C6A8) [NBP2-61855] - Analysis using C3C mAb against human C3C (AA: 1521-1649) recombinant protein. (Expected MW is 40.7 kDa)")
![Immunocytochemistry/Immunofluorescence: Complement C3c Antibody (4C6A8) [NBP2-61855] - Analysis of Hela cells using C3C mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/Complement-C3-Antibody-4C6A8-Immunocytochemistry-Immunofluorescence-NBP2-61855-img0003.jpg)
![Immunohistochemistry-Paraffin: Complement C3c Antibody (4C6A8) [NBP2-61855] - Analysis of paraffin-embedded bladder cancer tissues using C3C mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Complement-C3-Antibody-4C6A8-Immunohistochemistry-NBP2-61855-img0005.jpg)
![Flow Cytometry: Complement C3c Antibody (4C6A8) [NBP2-61855] - Analysis of Hela cells using C3C mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Complement-C3-Antibody-4C6A8-Flow-Cytometry-NBP2-61855-img0002.jpg)
![Western Blot: Complement C3 Antibody (4C6A8) [NBP2-61855] - Analysis using C3C mAb against HEK293 (1) and C3C (AA: 1521-1649)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Complement-C3-Antibody-4C6A8-Western-Blot-NBP2-61855-img0007.jpg)
![Immunohistochemistry-Paraffin: Complement C3c Antibody (4C6A8) [NBP2-61855] - Analysis of paraffin-embedded ovarian cancer tissues using C3C mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Complement-C3-Antibody-4C6A8-Immunohistochemistry-NBP2-61855-img0004.jpg)
![ELISA: Complement C3c Antibody (4C6A8) [NBP2-61855] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Complement-C3-Antibody-4C6A8-ELISA-NBP2-61855-img0001.jpg)
![Western Blot: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD80 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD80.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Western-Blot-NBP2-70364-img0001.jpg "Western Blot: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD80 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD80.")
![Immunocytochemistry/Immunofluorescence: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY CD80.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-70364-img0002.jpg)
![Immunohistochemistry: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of paraffin-embedded Human pancreas tissue using anti-CD80 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70364-img0008.jpg)
![Immunohistochemistry: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-CD80 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70364-img0003.jpg)
![Immunohistochemistry: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of paraffin-embedded Carcinoma of Human lung tissue using anti-CD80 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70364-img0004.jpg)
![Immunohistochemistry: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-CD80 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70364-img0005.jpg)
![Immunohistochemistry: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of paraffin-embedded Human colon tissue using anti-CD80 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70364-img0006.jpg)
![Immunohistochemistry: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of paraffin-embedded Human liver tissue using anti-CD80 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70364-img0007.jpg)
![Immunohistochemistry: B7-1/CD80 Antibody (OTI2E5) - Azide and BSA Free [NBP2-70364] - Staining of paraffin-embedded Human prostate tissue using anti-CD80 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-OTI2E5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70364-img0009.jpg)
![Western Blot: CD40 Ligand/TNFSF5 Antibody (JM11-34) [NBP2-66756] - Western blot analysis of CD40 Ligand/TNFSF5 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: mouse liver tissue lysate Lane 2: rat liver tissue lysate Lane 2: mouse bone marrow tissue lysate](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-JM11-34-Western-Blot-NBP2-66756-img0007.jpg "Western Blot: CD40 Ligand/TNFSF5 Antibody (JM11-34) [NBP2-66756] - Western blot analysis of CD40 Ligand/TNFSF5 on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: mouse liver tissue lysate Lane 2: rat liver tissue lysate Lane 2: mouse bone marrow tissue lysate")
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (JM11-34) [NBP2-66756] - Staining CD40L in NIH-3T3 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-JM11-34-Immunocytochemistry-Immunofluorescence-NBP2-66756-img0006.jpg)
![Immunohistochemistry-Paraffin: CD40 Ligand/TNFSF5 Antibody (JM11-34) [NBP2-66756] - Analysis of paraffin-embedded human spleen tissue using anti- CD40L antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-JM11-34-Immunohistochemistry-Paraffin-NBP2-66756-img0004.jpg)
![Flow Cytometry: CD40 Ligand/TNFSF5 Antibody (JM11-34) [NBP2-66756] - Analysis of THP-1 cells with CD40L antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the secondary antibody.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-JM11-34-Flow-Cytometry-NBP2-66756-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (JM11-34) [NBP2-66756] - Staining CD40L in Hela cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-JM11-34-Immunocytochemistry-Immunofluorescence-NBP2-66756-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (JM11-34) [NBP2-66756] - Staining CD40L in MCF-7 cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-JM11-34-Immunocytochemistry-Immunofluorescence-NBP2-66756-img0003.jpg)